Zydus Lifesciences Cash Flow Annual

Trade
BSE: 532321 | NSE: ZYDUSLIFE | ISIN: INE010B01027 | Sector: Biotechnology & Drugs
962.70 +14.00 (1.48%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Net Income/ Starting Line 4,808.902,589.702,838.102,284.80
Depreciation/ Depletion 764.10722.70736.10724.80
Non- Cash Items -99.90516.30-162.70507.00
Changesin Working Capital -2,239.20-1,139.90-1,333.30-331.50
Cashfrom Operating Activities 3,233.902,688.802,078.203,185.10
Capital Expenditures -906.60-1,030.90-1,202.60-854.00
Other Investing Cash Flow Items Total -568.602,202.102,357.00131.50
Cashfrom Investing Activities -1,475.201,171.201,154.40-722.50
Financing Cash Flow Items -72.90-126.20-111.10-323.30
Total Cash Dividends Paid -621.00-267.10-372.20-1.50
Issuance( Retirement)of Stock Net -725.00-863.20-986.60
Issuance( Retirement)of Debt Net -391.50-3,143.90-385.00-3,210.70
Cashfrom Financing Activities -1,810.40-4,400.40-868.30-2,548.90
Foreign Exchange Effects -23.106.608.60-4.20
Net Changein Cash -74.80-533.802,372.90-90.50
Cash Taxes Paid 1,285.80592.00674.60345.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts